ArticleJournal for immunotherapy of cancer2018

Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.

Zoë Blake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.